Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna E. Caprifico"'
Publikováno v:
BMC Medical Imaging, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Introduction The treatment of preinvasive lesions is more effective than treating invasive disease, hence detecting cancer at its early stages is crucial. However, currently, available screening methods show various limitations in terms of s
Externí odkaz:
https://doaj.org/article/6df1dd30356148f08bf579024dbf5d44
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1840 (2022)
Clustered regularly interspaced short palindromic repeat (CRISPR) and the associated Cas endonuclease (Cas9) is a cutting-edge genome-editing technology that specifically targets DNA sequences by using short RNA molecules, helping the endonuclease Ca
Externí odkaz:
https://doaj.org/article/b08e78c70edb43a9b1522c97d3d1c686
Publikováno v:
Pharmaceutics, Vol 12, Iss 11, p 1013 (2020)
The major impediment to the delivery of therapeutics to the brain is the presence of the blood-brain barrier (BBB). The BBB allows for the entrance of essential nutrients while excluding harmful substances, including most therapeutic agents; hence, b
Externí odkaz:
https://doaj.org/article/e1ab234c438943b09953fbbb5e170ead
Publikováno v:
Drug discovery today. 26(8)
Numerous properties of chitosan have led to its extensive use in the\ud formulation of nanomaterials for drug delivery. However, the\ud cationic surface of chitosan-based nanoparticles adsorbs proteins\ud upon exposure to biological fluids, forming a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd1b8a9a770a5bb2a2f8417b9fbaa82d
https://pubmed.ncbi.nlm.nih.gov/33892141
https://pubmed.ncbi.nlm.nih.gov/33892141
Oral administration of drugs is one of the most patient-friendly drug delivery routes. However, drug bioavailability via the oral route remains poor due to the harsh gastrointestinal environment. In recent years, many nanocarriers have been designed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178e556e146d4a627f867998e3dcfbac
https://eprints.kingston.ac.uk/id/eprint/46700/6/Caprifico-A-46700-AAM.pdf
https://eprints.kingston.ac.uk/id/eprint/46700/6/Caprifico-A-46700-AAM.pdf
Publikováno v:
Macromolecular bioscience. 21(1)
Chitosan-based nanocarriers (ChNCs) are considered suitable drug carriers due to their ability to encapsulate a variety of drugs and cross biological barriers to deliver the cargo to their target site. Fluorescein isothiocyanate-labeled chitosan-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809d5229e89ca4763c99382eb5deae41
https://pubmed.ncbi.nlm.nih.gov/33016007
https://pubmed.ncbi.nlm.nih.gov/33016007
Publikováno v:
Pharmaceutics, Vol 12, Iss 1013, p 1013 (2020)
Pharmaceutics
Pharmaceutics
The major impediment to the delivery of therapeutics to the brain is the presence of the blood-brain barrier (BBB). The BBB allows for the entrance of essential nutrients while excluding harmful substances, including most therapeutic agents; hence, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7791d5a8c4b67994b0602db9811d6e27
https://doi.org/10.3390/pharmaceutics12111013
https://doi.org/10.3390/pharmaceutics12111013